Literature DB >> 29476286

Disability progression in multiple sclerosis: a Tunisian prospective cohort study.

Emna Hentati1,2, Samia Ben Sassi3,4, Fatma Nabli1,2, Tarek Mabrouk1,2, Mourad Zouari1,2, Fayçal Hentati1,2.   

Abstract

Data regarding multiple sclerosis (MS) course in North Africans are scarce and mainly retrospective. To prospectively assess disability progression of multiple sclerosis in Tunisia. Analysis was performed in 600 patients from the MS database of the Mongi Ben Hmida National Institute of Neurology (Tunis, Tunisia), prospectively recorded over a 10-year period. Two MS phases were defined: phase 1, from MS clinical onset to Disability Status Scale (DSS) 3; and phase 2, from DSS 3 to DSS 6. Median durations of both phases and median ages at DSS 3 and DSS 6 were estimated using the Kaplan-Meier method. Median ages at DSS scores 3 and 6 were 48 years (95% confidence interval (CI), 45-50) and 53 years (95% CI, 52-55), respectively. Median time from onset to DSS 3 (phase 1 duration) was 9 years (95% CI, 7-11) and median time to DSS 6 was 12 years (95% CI, 10-15). Median phase 2 duration was 3 years (95% CI, 2.4-3.6). Males and progressive-onset patients had faster disability worsening during the first phase of the disease. Conversely, disability progression during the second phase was independent of gender and MS phenotype at onset. Our study showed that disability progression followed a two-stage process in Tunisian MS patients with however a more aggressive course compared to that in Westerners.

Entities:  

Keywords:  Disability progression; Epidemiology; Multiple sclerosis; North Africa; Prognosis; Tunisia

Mesh:

Year:  2018        PMID: 29476286     DOI: 10.1007/s10072-018-3295-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  3 in total

1.  Combined upper limb and breathing exercise programme for pain management in ambulatory and non-ambulatory multiple sclerosis individuals: part II analyses from feasibility study.

Authors:  Tanja Grubić Kezele; Matea Babić; Tamara Kauzlarić-Živković; Tamara Gulić
Journal:  Neurol Sci       Date:  2019-08-17       Impact factor: 3.307

2.  Exploring the feasibility of a mild and short 4-week combined upper limb and breathing exercise program as a possible home base program to decrease fatigue and improve quality of life in ambulatory and non-ambulatory multiple sclerosis individuals.

Authors:  Tanja Grubić Kezele; Matea Babić; Dinko Štimac
Journal:  Neurol Sci       Date:  2019-01-18       Impact factor: 3.307

3.  The use of Modified Rio score for determining treatment failure in patients with multiple sclerosis: retrospective descriptive case series study.

Authors:  Mesude Tutuncu; Ayse Altintas; Burcu V Dogan; Ugur Uygunoglu; Nilufer Kale Icen; Ayse Deniz Elmalı; Eda Coban; Bengi G Alpaslan; Aysun Soysal
Journal:  Acta Neurol Belg       Date:  2020-08-31       Impact factor: 2.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.